1. Dettmers C, Teske U, Hamzei F, Uswatte G, Taub E, Weiller C. Distributed form of constraint-induced movement therapy improves functional outcome and quality of life after stroke. Arch Phys Med Rehabil 2005;86:204-209.
  2. Grotta JC, Noser EA, Ro T et al. Constraint-induced movement therapy. Stroke 2004;35:2699-2701.
  3. Page S, Levine P. Forced use after TBI: promoting plasticity and function through practice. Brain Inj 2003;17:675-684.
  4. Shaw SE, Morris DM, Uswatte G, McKay S, Meythaler JM, Taub E. Constraint-induced movement therapy for recovery of upper-limb function following traumatic brain injury. J Rehabil Res Dev 2005;42:769-778.
  5. Djergaian RS. Management of musculoskeletal complications. In: Horn LJ, Zasler ND, eds. Medical rehabilitation of traumatic brain injury. Toronto: Mosby; 1996;459-478.
  6. Lannin NA, Horsley SA, Herbert R, McCluskey A, Cusick A. Splinting the hand in the functional position after brain impairment: a randomized, controlled trial. Arch Phys Med Rehabil 2003;84:297-302.
  7. Mayer NH. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion. Muscle Nerve Suppl 1997;6:S1-13.
  8. Neistadt ME. The effects of different treatment activities on functional fine motor coordination in adults with brain injury. Am J Occup Ther 1994;48:877-882.
  9. Kriz G, Hermsdorfer J, Marquardt C, Mai N. Feedback-based training of grip force control in patients with brain damage. Arch Phys Med Rehabil 1995;76:653-659.
  10. Mayer NH, Esquenazi A, Childers MK. Common patterns of clinical motor dysfunction. Muscle Nerve Suppl 1997;6:S21-S35.
  11. Lance JW. The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture. Neurology 1980;30:1303-1313.
  12. Gormley ME, Jr., O'Brien CF, Yablon SA. A clinical overview of treatment decisions in the management of spasticity. Muscle Nerve Suppl 1997;6:S14-S20.
  13. Katz RT, Campagnolo DI. Pharmacological management of spasticity. In: Katz RT, ed. Spasticity: State of the Art Reviews; Physical Medicine and Rehabilitation, Volume 8. Philadelphia: Hanley and Belfus; 1993;473-480.
  14. Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Suppl 1997;6:S92-120.
  15. Meythaler JM, Guin-Renfroe S, Johnson A, Brunner RM. Prospective assessment of tizanidine for spasticity due to acquired brain injury. Arch Phys Med Rehabil 2001;82:1155-1163.
  16. Meythaler JM, Clayton W, Davis LK, Guin-Renfroe S, Brunner RC. Orally delivered baclofen to control spastic hypertonia in acquired brain injury. J Head Trauma Rehabil 2004;19:101-108.
  17. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-1194.
  18. Yablon SA, Agana BT, Ivanhoe CB, Boake C. Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: an open-labeled trial. Neurology 1996;47:939-944.
  19. Fock J, Galea MP, Stillman BC, Rawicki B, Clark M. Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury. Brain Inj 2004;18:57-63.
  20. van Rhijn J, Molenaers G, Ceulemans B. Botulinum toxin type A in the treatment of children and adolescents with an acquired brain injury. Brain Inj 2005;19:331-335.
  21. Meythaler JM, Guin-Renfroe S, Hadley MN. Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report. Am J Phys Med Rehabil 1999;78:247-254.
  22. Meythaler JM, McCary A, Hadley MN. Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report. J Neurosurg 1997;87:415-419.
  23. Meythaler JM, DeVivo MJ, Hadley M. Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury. Arch Phys Med Rehabil 1996;77:461-466.
  24. Stokic DS, Yablon SA, Hayes A. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury. Arch Phys Med Rehabil 2005;86:1801-1806.
  25. Becker R, Alberti O, Bauer BL. Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol 1997;244:160-166.
  26. Horn TS, Yablon SA, Stokic DS. Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Arch Phys Med Rehabil 2005;86:1127-1133.
  27. Dario A, Di Stefano MG, Grossi A, Casagrande F, Bono G. Long-term intrathecal Baclofen infusion in supraspinal spasticity of adulthood. Acta Neurol Scand 2002;105:83-87.
  28. Francois B, Vacher P, Roustan J et al. Intrathecal baclofen after traumatic brain injury: early treatment using a new technique to prevent spasticity. J Trauma 2001;50:158-161.
  29. Francisco GE, Hu MM, Boake C, Ivanhoe CB. Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury. Brain Inj 2005;19:359-364.
  30. Meythaler JM, Guin-Renfroe S, Grabb P, Hadley MN. Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. Arch Phys Med Rehabil 1999;80:13-19.
  31. Woo BH, Nesathurai S. The Rehabilitation of People with Traumatic Brain Injury. 1st ed. Boston, MA: Blackwell Science, 2000.
  32. Mysiw WJ, Fugate LP.., Clinchot DM. Assessment, Early Rehabilitation, Intervention, and Prevention. In: Zasler ND KDZR, ed. Brain Injury Medicine. New York, NY: Demos Medical Publishing; 2007;283-304.
  33. Zasler ND, Katz DI, Zafonte RD. Brain Injury Medicine. New York: Demos Medical Publishing, 2007.
  34. Mayer NH, Esquenazi A, Keenan MAE. Assessing and Treating Muscle Overactivity in the Upper Motoneuron Syndrome. In: Zasler ND, Katz DI, Zafonte RD, eds. Brain Injury Medicine. 1st ed. New York, NY: Demos Medical Publishing; 2007;615-653.
  35. Meythaler JM. Post-Acute Management Consequences of TBI.  2008.
  36. Marshall S, Teasell R, Aubut J, Lippert C. Motor & Sensory Impairment Remediation Post Acquired Brain Injury. In: Teasell R, Marshall S, Cullen N., Bayley M., eds. Evidence-Based Review of Moderate to Severe Acquired Brain Injury. 4th ed. Ontario Neurotrauma Foundation; 2010.
  37. Yarkony GM, Sahgal V. Contractures. A major complication of craniocerebral trauma. Clin Orthop Relat Res 1987;93-96.
  38. Mortenson PA, Eng JJ. The use of casts in the management of joint mobility and hypertonia following brain injury in adults: a systematic review. Phys Ther 2003;83:648-658.
  39. Marshall S, Teasell R, Aubut J, Lippert C. Motor & Sensory Impairment Remediation Post Acquired Brain Injury. In: Teasell R, Marshall S, Cullen N., Bayley M., eds. Evidence-Based Review of Moderate to Severe Acquired Brain Injury. 4th ed. Ontario Neurotrauma Foundation; 2008.
  40. Pohl M, Ruckriem S, Mehrholz J, Ritschel C, Strik H, Pause MR. Effectiveness of serial casting in patients with severe cerebral spasticity: a comparison study. Arch Phys Med Rehabil 2002;83:784-790.
  41. Moseley AM. The effect of casting combined with stretching on passive ankle dorsiflexion in adults with traumatic head injuries. Phys Ther 1997;77:240-247.
  42. Kent H, Hershler C, Conine TA, Hershler R. Case-control study of lower extremity serial casting in adult patients with head injury. Physiother Can 1990;42:189-191.
  43. Singer BJ, Singer KP, Allison GT. Evaluation of extensibility, passive torque and stretch reflex responses in triceps surae muscles following serial casting to correct spastic equinovarus deformity. Brain Inj 2003;17:309-324.
  44. Singer BJ, Jegasothy GM, Singer KP, Allison GT. Evaluation of serial casting to correct equinovarus deformity of the ankle after acquired brain injury in adults. Arch Phys Med Rehabil 2003;84:483-491.
  45. Verplancke D, Snape S, Salisbury CF, Jones PW, Ward AB. A randomized controlled trial of botulinum toxin on lower limb spasticity following acute acquired severe brain injury. Clin Rehabil 2005;19:117-125.
  46. Conine TA, Sullivan T, Mackie T, Goodman M. Effect of serial casting for the prevention of equinus in patients with acute head injury. Arch Phys Med Rehabil 1990;71:310-312.
  47. Hill J. The effects of casting on upper extremity motor disorders after brain injury. Am J Occup Ther 1994;48:219-224.
  48. Grissom SP, Blanton S. Treatment of upper motoneuron plantarflexion contractures by using an adjustable ankle-foot orthosis. Arch Phys Med Rehabil 2001;82:270-273.
  49. Caplan LR. Neurologic Management Plan. In: Ozer MN, Materson RS, Caplan LR, eds. Management of Persons with Stroke. 1st ed. St Louis, MI: Mosby; 1994;61-113.